Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2024 Financial Results
Tenon Medical (NASDAQ:TNON), a company focused on Sacroiliac Joint (SIJ) disorders treatment, has scheduled its Q4 and full year 2024 financial results release for March 20, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day, featuring a Q&A session with its covering analyst.
The earnings call replay will be accessible through April 3, 2025, via Tenon's Investor Relations website or by telephone using the access code 13751490.
Tenon Medical (NASDAQ:TNON), un'azienda focalizzata sul trattamento dei disturbi dell'articolazione sacroiliaca (SIJ), ha programmato la pubblicazione dei risultati finanziari per il Q4 e l'intero anno 2024 per il 20 marzo 2025, dopo la chiusura del mercato. L'azienda terrà una conference call alle 16:30 ora orientale dello stesso giorno, con una sessione di domande e risposte con l'analista di riferimento.
La registrazione della call sugli utili sarà accessibile fino al 3 aprile 2025, tramite il sito web delle Relazioni con gli Investitori di Tenon o per telefono utilizzando il codice di accesso 13751490.
Tenon Medical (NASDAQ:TNON), una empresa centrada en el tratamiento de trastornos de la articulación sacroilíaca (SIJ), ha programado la publicación de sus resultados financieros para el Q4 y el año completo 2024 para el 20 de marzo de 2025, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia a las 4:30 p.m. hora del Este el mismo día, con una sesión de preguntas y respuestas con su analista asignado.
La repetición de la llamada de ganancias estará disponible hasta el 3 de abril de 2025, a través del sitio web de Relaciones con Inversores de Tenon o por teléfono utilizando el código de acceso 13751490.
테논 메디컬 (NASDAQ:TNON), 천골 관절(SIJ) 장애 치료에 집중하는 회사,는 2024년 4분기 및 연간 재무 결과 발표를 2025년 3월 20일 시장 마감 후로 예정했습니다. 회사는 같은 날 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜을 개최하며, 해당 분석가와의 질의응답 세션이 포함됩니다.
실적 발표 콜의 재생은 2025년 4월 3일까지 테논의 투자자 관계 웹사이트를 통해 또는 전화로 접근 코드 13751490을 사용하여 가능합니다.
Tenon Medical (NASDAQ:TNON), une entreprise axée sur le traitement des troubles de l'articulation sacro-iliaque (SIJ), a programmé la publication de ses résultats financiers pour le Q4 et l'année complète 2024 pour le 20 mars 2025, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 16h30, heure de l'Est, le même jour, avec une session de questions-réponses avec son analyste référent.
La rediffusion de l'appel sur les bénéfices sera accessible jusqu'au 3 avril 2025, via le site web des Relations Investisseurs de Tenon ou par téléphone en utilisant le code d'accès 13751490.
Tenon Medical (NASDAQ:TNON), ein Unternehmen, das sich auf die Behandlung von Sakroiliakalgelenk (SIJ) Störungen konzentriert, hat die Veröffentlichung seiner finanziellen Ergebnisse für Q4 und das gesamte Jahr 2024 für den 20. März 2025 nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz veranstalten, die eine Frage- und Antwortsitzung mit dem zuständigen Analysten beinhaltet.
Die Wiederholung der Gewinnanruf wird bis zum 3. April 2025 über die Investor-Relations-Website von Tenon oder telefonisch mit dem Zugangscode 13751490 zugänglich sein.
- None.
- None.
LOS GATOS, CA / ACCESS Newswire / March 7, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the fourth quarter and full year 2024 ended December 31, 2024 after market close on Thursday, March 20, 2025. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analyst.
Date: | Thursday, March 20, 2025 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through April 3, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13751490.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Tenon Medical (TNON) release its Q4 2024 earnings?
How can investors access TNON's Q4 2024 earnings call?
Until when will TNON's Q4 2024 earnings call replay be available?
What is the replay access code for TNON's Q4 2024 earnings call?
